Zafirlucast in corticosteroid sensitive - And resistant bronchial asthma

Advances in Clinical and Experimental Medicine

Volumn 10, Issue 4, 2001, Pages 337-347

  Wytrychowski, Krzysztof ^a   Patrowski, Janusz ^a   Kuźniar, Tomasz ^a   Malolepszy, Józef ^a  

^a Katedra i Klinika   (Poland)

Author keywords

Steroid resistant bronchial asthma; Zafirlucast

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FENOTEROL; FORMOTEROL; HYDROCORTISONE; INTERFERON; INTERLEUKIN 2; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; PREDNISONE; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SENSITIVITY; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; PEAK EXPIRATORY FLOW; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM;

EID: 0035700489     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Molecular mechanism of steroid action in asthma
2. Steroid resistance in bronchial asthma
3. Cutaneus vasoconstrictor response to glucocoticoids in asthma
4. Glucocorticoid resistance in chronic asthma
5. Glucocorticoid receptor characteristic in monocytes of patients with corticosteroid-resistant bronchial asthma
6. Steroid resistant asthma. Cellular mechanism contributing to inadequate response to glucocorticoid therapy
7. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation
8. Long-term methotrexate treatment in corticosteroid dependent asthma
9. Cyclosporin for steroid dependent asthma
10. The use of auranofin in steroid dependent asthma
11. Application of CAST-ELISA test in corticosteroid resistant chronic asthma
12. Leki antyleukotrienowe w leczeniu astmy
13. Role of cysteinyl leukotriene receptor antagonist in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease"
14. Effectiveness of the leukotriene receptor antagonist zafirlucast for mild-to-moderate asthma
15. Montelucast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma
16. Randomised, placebo controlled trial of effect of a lekotriene receptor antagonist, montelucast, on tapering inhaled corticosteroids in asthmatic patients
17. A multicentre study to assess the steroid-sparing potential of accolate (zafirlucast)
18. Test kurczliwości naczyń skórnych w ocenie kortykosteroidoopornej astmy oskrzelowej. Post
19. The St George's Respiratory Questionnaire
20. Wplyw osteoporozy oraz zmian okresu klimakterycznego na jakość zycia u kobiet chorych na astme oskrzelowa
21. Leukotrienenes are potent constrictors of human bronchi
22. The leukotrienes: Mediators of chronic inflammation in asthma
23. Asthma and leukotrienes: Antileukotrienes as novel antiasthmatic drugs
24. Leukotriene antagonist and synthesis inhibitors. New direction in asthma therapy
25. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204, 219, a potent leukotriene D4 receptor antagonist
26. The leukotriene antagonist ICI-204, 219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics
27. Effect of cysteinyl-leukotriene receptor antagonist ISI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
28. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion
29. Effect of oral prednisone on airway inflammatory mediators in atopic asthma